BeOne Medicines (ONC) Share-based Compensation (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33% |
| Dec 31, 2025 | -12.11% |
| Sep 30, 2025 | -6.63% |
| Jun 30, 2025 | 57.95% |
| Mar 31, 2025 | -11.28% |
| Dec 31, 2024 | -6.17% |
| Sep 30, 2024 | -12.20% |
| Jun 30, 2024 | 47.33% |
| Mar 31, 2024 | -4.58% |
| Dec 31, 2023 | -3.21% |
| Sep 30, 2023 | -7.13% |
| Jun 30, 2023 | 37.24% |
| Mar 31, 2023 | -3.59% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -3.85% |
| Jun 30, 2022 | 24.03% |
| Mar 31, 2022 | 4.04% |
| Dec 31, 2021 | -6.06% |
| Sep 30, 2021 | 3.53% |
| Jun 30, 2021 | 41.36% |
| Mar 31, 2021 | -7.34% |
| Dec 31, 2020 | -1.66% |
| Sep 30, 2020 | 10.62% |
| Jun 30, 2020 | 18.86% |
| Mar 31, 2020 | -0.23% |
| Dec 31, 2019 | 4.14% |
| Sep 30, 2019 | 12.93% |
| Jun 30, 2019 | 23.53% |
| Mar 31, 2019 | 1.67% |
| Dec 31, 2018 | 3.29% |
| Sep 30, 2018 | 34.82% |
| Jun 30, 2018 | 7.16% |
| Mar 31, 2018 | 5.67% |
| Dec 31, 2017 | 23.52% |
| Sep 30, 2017 | 88.18% |
| Jun 30, 2017 | 18.19% |
| Mar 31, 2017 | 51.81% |
| Dec 31, 2016 | 42.03% |
| Sep 30, 2016 | 116.26% |
| Jun 30, 2016 | -50.84% |
| Mar 31, 2016 | 20.57% |
| Dec 31, 2015 | -55.01% |
| Sep 30, 2015 | 429.56% |
| Jun 30, 2015 | -60.67% |